Detecting kidney disease early in preterm infants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to understand the natural history of kidney function and size in preterm infants during their first two years of life. It focuses on infants born preterm and of low birth weight, who are at increased risk for developing cardiovascular and renal diseases later in life. The study will utilize standard serum and urine markers along with non-invasive ultrasound technology to identify early markers of kidney injury. The ultimate goal is to enable early diagnosis and potential interventions to prevent the progression of kidney disease and hypertension in these vulnerable infants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Stable preterm infants \<37 weeks' gestational age; Stable term infants \>37 weeks' gestational age

Exclusion Criteria:

\<24 weeks gestational age; \<600 grams Any anomalies of the genital-urinary or gastrointestinal tract

Where it's running

• University of Miami/ Holtz Children's Hospital
  Miami, Florida, United States Recruiting

Study contacts

• Principal investigator: Marissa J DeFreitas, MD — University of Miami
• Study coordinator: Marissa J DeFreitas, MD
• Email: MDefreitas@med.miami.edu
• Phone: 305-585-6726

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

• Gemini multi-organ denervation for uncontrolled high blood pressure

  The Gemini System is being tested to see if multi-organ denervation is safe and can lower blood pressure in adults with uncontrolled hypertension, with or without high cardiovascular risk.

  Recruiting at 18 sites Medtronic Vascular · Stanford, California and 17 other locations · NCT06907147

• Effects of green propolis extract and royal jelly on hypertension and chronic kidney disease

  This study is testing if a combination of green propolis extract and royal jelly can help people with high blood pressure and chronic kidney disease feel better.

  Recruiting at 2 sites Universidade Federal Fluminense · Rio de Janeiro, Rio de Janeiro and 1 other locations · NCT06288204

• Understanding chronic kidney disease in Sub-Saharan Africa

  This study is trying to understand how common chronic kidney disease is in Sub-Saharan Africa and what factors might be causing it by looking at the health and lifestyle of adults in the Bagamoyo district.

  Recruiting Swiss Tropical & Public Health Institute · Bagamoyo, Pwani Region · NCT05881447

• Improving health for Black COVID-19 survivors and their caregivers

  This study is testing a telehealth program to help Black COVID-19 survivors and their caregivers improve their health and manage chronic conditions better.

  Recruiting University of South Carolina · Columbia, South Carolina · NCT05370014

• Study on chronic kidney disease in American Indian populations

  This study looks at chronic kidney disease and heart problems in American Indians to see what makes their health different and to gather important health information for future research.

  Recruiting at 2 sites University of New Mexico · Phoenix, Arizona and 2 other locations · NCT04185844

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.